Genetic Polymorphism of Angiotensin Converting Enzyme and Risk of Coronary Restenosis after Percutaneous Transluminal Coronary Angioplasties: Evidence from 33 Cohort Studies

por Wang, Shen, Dai, Yuxiang, Chen, Lingling, Dong, Zhibing, Chen, Yunpeng, Li, Chenguang, Zhong, Xin, Lin, Wenhui, Zhang, Jifu
Publicado 2013

Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1

por Cai, Jing, Lin, Kaiying, Cai, Wei, Lin, Yuan, Liu, Xincheng, Guo, Li, Zhang, Jifu, Xu, Wencang, Lin, Ziqing, Wong, Chun Wa, Sander, Max, Hu, Jun, Yan, Guangmei, Zhu, Wenbo, Liang, Jiankai
Publicado 2020

DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage

por Xiao, Xiao, Liang, Jiankai, Huang, Chunlong, Li, Kai, Xing, Fan, Zhu, Wenbo, Lin, Ziqing, Xu, Wencang, Wu, Guangen, Zhang, Jifu, Lin, Xi, Tan, Yaqian, Cai, Jing, Hu, Jun, Chen, Xueqin, Huang, Youwei, Qin, Zixi, Qiu, Pengxin, Su, Xingwen, Chen, Lijun, Lin, Yuan, Zhang, Haipeng, Yan, Guangmei
Publicado 2018